Displaying drugs 2501 - 2525 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Ethyl hydroxybenzoate | 166.1739 C9H10O3 |  | Not Annotated | Standardized Chemical Allergen |
| Grepafloxacin | 359.3947 C19H22FN3O3 |  | A fluoroquinolone antibiotic used to treat various gram positive and gram negative bacterial infections. | Anti-Bacterial Agents |
| Brigatinib | 584.1 C29H39ClN7O2P |  | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Tranexamic acid | 157.2102 C8H15NO2 |  | An antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. | Amino Acids |
| Dabrafenib | 519.562 C23H20F3N5O2S2 |  | A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Fruquintinib | 393.399 C21H19N3O5 |  | A VEGF receptor inhibitor used to treat metastatic colorectal cancer. | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| Avibactam | 265.24 C7H11N3O6S |  | A non-β-lactam β-lactamase inhibitor used in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and hospital or ventilator-acquired pneumonia. | beta-Lactamase Inhibitors |
| Esomeprazole | 345.416 C17H19N3O3S |  | A proton pump inhibitor used to treat GERD, reduce the risk of NSAID associated gastric ulcers, eradicate H. pylori, and to treat conditions causing gastric acid hypersecretion. | Propionates |
| Vibegron | 444.535 C26H28N4O3 |  | A beta-3 adrenergic agonist the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults. | Adrenergic Agonists / Adrenergic beta-3 Receptor Agonists / Adrenergic beta-Agonists / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs for Urinary Frequency and Incontinence / Genito Urinary System and Sex Hormones / Genitourinary Smooth Muscle Relaxants / P-glycoprotein substrates / Pyrimidines / Selective Beta 3-adrenergic Agonists / Urologicals |
| Sofosbuvir | 529.458 C22H29FN3O9P |  | A direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents. | Antivirals for treatment of HCV infections |
| Benzoin | 212.2439 C14H12O2 |  | No approved therapeutic indications. | Acetophenones |
| Methyl salicylate | 152.1473 C8H8O3 |  | A topical counter-irritant used for the symptomatic relief of acute musculoskeletal pain in the muscles, joints, and tendons. | Antirheumatic Agents / Betula / Fixatives / Gaultheria |
| Framycetin | 614.6437 C23H46N6O13 |  | An aminoglycoside antibiotic used in various formulations and combinations with other agents to treat hemorrhoids, eye and ear infections, and to reduce nasal carriage of staphylococcus. | Medicated Dressings With Antiinfectives |
| Carglumic acid | 190.154 C6H10N2O5 |  | An analog of N-acetylglutamate (NAG) used for the treatment of acute and chronic hyperammonemia in patients with N-acetylglutamate synthase (NAGS) deficiency. | Amino Acids and Derivatives |
| Baricitinib | 371.42 C16H17N7O2S |  | A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist. | Selective Immunosuppressants |
| Omidenepag isopropyl | 520.61 C26H28N6O4S |  | An agonist of the prostaglandin EP2 receptor indicated for the reduction of elevated intraocular pressure. | Antiglaucoma Agents / Hypotensive Agents / Ophthalmic Solutions / Ophthalmics / Prodrugs / Pyrazoles / Pyridines / Receptors, Prostaglandin E, EP2 Subtype, agonists / Sulfonamides |
| Selenomethionine Se-75 | 192.071 C5H11NO2Se |  | Not Annotated | Organoselenium Compounds |
| Mannitol busulfan | 338.34 C8H18O10S2 |  | Mm has been used in trials studying the treatment of Cocaine Dependence and Diabetes Mellitus, Type 2. | Agents causing hyperkalemia |
| Tilmanocept | Not Annotated |  | Tilmanocept is under investigation in clinical trial NCT03241446 (Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis... | Not Annotated |
| Ferric ammonium citrate | 264.997 C6H11FeNO7 |  | Not Annotated | Paramagnetic Contrast Media |
| Nebivolol | 405.435 C22H25F2NO4 |  | A beta blocking agent used to treat hypertension and aid in the management of heart failure. | Antihypertensive Agents / Beta blocking agents and calcium channel blockers / Beta Blocking Agents, Selective / Beta Blocking Agents, Selective, and Thiazides |
| Tazarotene | 351.462 C21H21NO2S |  | An acetylenic retinoid used to treat fine wrinkles, mottled pigmentation of the skin, acne vulgaris, and plaque psoriasis. | Keratolytic Agents / Prodrugs / Retinoids / Teratogens |
| Zoledronic acid | 272.0896 C5H10N2O7P2 |  | A bisphosphonate used to treat malignancy associated hypercalcemia, multiple myeloma, and bone metastasis from solid tumors. | Bisphosphonates / Bone Density Conservation Agents / Imidazoles |
| Ethyl salicylate | 166.1739 C9H10O3 |  | A salicylate indicated in the treatment of sports related pain. | Acids, Carbocyclic / Benzene Derivatives / Benzoates / Hydroxy Acids / Hydroxybenzoates / Phenols |
| Octisalate | 250.3334 C15H22O3 |  | Ingredient in sunscreens for protection against damage effects of sun light, provides protection from sunburns, aging and skin cancer. | Sunscreen Agents |
Displaying drugs 2501 - 2525 of 2785 in total